Mov Disord by Dong, Jing et al.
Dietary fat intake and risk for Parkinson’s disease
Jing Dong, PhD1,*, John D. Beard, MPH1,2, David M. Umbach, PhD3, YikYung Park, ScD4, 
Xuemei Huang, MD, PhD5, Aaron Blair, PhD4, Freya Kamel, PhD1, and Honglei Chen, MD, 
PhD1
1Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research 
Triangle Park, NC, USA
2Department of Epidemiology, Gillings School of Global Public Health, University of North 
Carolina at Chapel Hill, Chapel Hill, NC, USA
3Biostatistics Branch, National Institute of Environmental Health Sciences, NIH, Research 
Triangle Park, NC, USA
4Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, 
USA
5Department of Neurology, Pennsylvania State University—Milton S. Hershey Medical Center, 
Hershey, Pennsylvania, USA
Abstract
BACKGROUND—Previous epidemiological studies have generated inconsistent results 
regarding the associations between dietary fat intakes and risk for Parkinson’s disease (PD). We 
therefore prospectively examined these associations in the NIH-AARP Diet and Health Study.
METHODS—A 124-item food frequency questionnaire was administered at baseline in 1995–
1996, and PD diagnosis was self-reported at the follow-up survey in 2004–2006. A total of 1,087 
cases with a PD diagnosis between 2000 and 2006 and 299,617 controls were included in the 
analyses.
RESULTS—Overall, intakes of fats and other macronutrients were not associated with PD risk. 
However, we found a weak positive association between n-6 polyunsaturated fatty acids (PUFA) 
and the risk for PD. After adjusting for potential confounders, the odds ratio (OR) and 95% 
confidence interval (CI) between extreme quintiles of n-6 PUFA intake was 1.23 (95% CI=1.02–
1.49, P for trend=0.02). A similar association was observed for the intake of linoleic acid. Results 
were similar among men and among women.
CONCLUSIONS—Our study suggests that fat intake in general is not related to the risk for PD. 
The weak positive association between intake of n-6 PUFA and PD risk needs further 
investigation.
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Parkinson's disease (PD) is the second most common neurodegenerative disease and affects 
more than one million Americans 1. Although the exact mechanisms underlying PD 
pathogenesis are yet to be defined; oxidative stress, mitochondrial dysfunction, and 
inflammation may contribute to this process2–4. The brain is particularly susceptible to 
oxidative damage because of its high demand for oxygen and the presence of abundant iron 
and unsaturated fatty acids 5. In addition, polyunsaturated fatty acids (PUFA), which are 
essential components of neuronal and glial cell membranes, regulate the production of pro/
anti-inflammatory cytokines that may also contribute to neurodegenerative diseases such as 
PD 6.
Murine studies have shown that brain concentrations of fatty acids, such as PUFA, may be 
affected by dietary intake7, 8. Epidemiological studies on dietary fat intake and PD have 
generated inconsistent results, ranging from positive associations 9–12, to null 13, 14 or even 
inverse associations 15–20. We therefore prospectively examined the relationships between 
PD risk and intakes of total fat, specific types of fat, and other macronutrients in the NIH-
AARP Diet and Health Study.
Patients and Methods
Study population and PD case identification
The details of the NIH-AARP Diet and Health Study have been described previ-ously21. 
Briefly, in 1995–1996, a total of 566,398 members of AARP (formerly known as the 
American Association of Retired Persons), aged 50 to 71 years, were recruited into a large 
prospective study to evaluate roles of diet and lifestyle in the development of cancers and 
other chronic diseases. Participants were from six US states (California, Florida, Louisiana, 
New Jersey, North Carolina, and Pennsylvania) and two metropolitan areas (Atlanta, 
Georgia, and Detroit, Michigan). At enrollment, they reported a wide range of dietary 
intakes of macro- and micronutrients 21. From 2004 to 2006, a follow-up survey was 
conducted among surviving participants to update lifestyle exposures and to ascertain the 
occurrence of major chronic diseases, including PD. Participants were asked whether they 
had been diagnosed with PD by a physician and, if so, the year of diagnosis in the following 
categories: before 1985, 1985–1994, 1995–1999, or during or after 2000. A total of 318,257 
men and women responded to the follow-up survey and 2,432 participants reported a PD 
diagnosis.
Between 2007 and 2010, we contacted surviving PD patients to confirm self-reported PD 
diagnoses. Detailed procedures were published previously 22. Briefly, we first asked patients 
who self-reported PD to confirm their reports. We then asked their treating physician to 
complete a diagnostic questionnaire and to provide a copy of the patient’s medical records. 
The medical records were subsequently reviewed by a movement disorder specialist (X. H.). 
A case was confirmed if one of the following criteria was met: (1) the diagnosis was 
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confirmed by the treating physician, (2) the medical record included a final diagnosis of PD, 
or (3) at least two cardinal signs were present with one being resting tremor or bradykinesia, 
the disease course was progressive, and there was an absence of unresponsiveness to 
levodopa or other features suggesting an alternative diagnosis. Of the 1,069 physician 
responses received, 940 (87.9%) PD diagnoses were confirmed. The confirmation rate was 
similar across years of diagnosis: 83.3% for cases diagnosed before 1985, 92.8% for cases 
diagnosed in 1985–1994, 87.9% for cases diagnosed in 1995–1999, and 87.2% for cases 
diagnosed after 2000.
We excluded 15,760 subjects whose baseline questionnaires were completed by proxy from 
the 566,398 members of the cohort, and then subjects who reported extreme intakes (>2 
times the interquartile range above the 75th percentile or below the 25th percentile of log-
transformed intake) of total energy (n=3,726) and total fat (n=631). Inclusion of participants 
with extreme intakes however had little effect on the results (data not shown).
After these exclusions, a total of 546,281 baseline enrollees left and 309,619 of them also 
participated in the follow-up survey and therefore eligible for the current analyses. We 
further removed subjects who didn’t answer the questions about PD status in the follow-up 
questionnaire (n=7,054) or were reporting errors and misdiagnoses (n=905), and PD patients 
whose diagnosis were denied by themselves or treat physicians in the disease validation 
process (n=48). Because PD may take years to develop and our previous studies indicated 
dietary and behavioral changes 2–4 years prior to disease diagnosis 23, 24, we further 
excluded 908 self-reported cases diagnosed before 2000. This left us with a total of 1,087 
cases diagnosed between 2000 and 2006, and 299,617 controls in the primary analyses.
Exposure assessment
All study participants completed a mailed questionnaire at baseline that included a validated 
124-item food-frequency questionnaire (FFQ) and questions on demographics and lifestyle. 
The FFQ asked participants to report their typical consumption frequency and portion size of 
124 food items during the past year. Consumption frequency allows for 10 categories, 
ranging from never to two or more times per day for solid foods and never to six or more 
times per day for drinks. The portion size had three categories-small, medium, and large. 
Nutrient intakes were calculated from the 1994–1996 U.S. Department of Agriculture 
Continuing Survey of Food Intake by individuals 25. The FFQ was calibrated against two 
nonconsecutive 24-hour dietary recalls that were administered by telephone within a year of 
the baseline questionnaire (n =2,053) 21. The estimated energy-adjusted Pearson correlation 
coefficients for men and women, respectively, were 0.72 and 0.62 for total fat, 0.76 and 0.69 
for saturated fat, 0.71 and 0.62 for monounsaturated fat and 0.53 and 0.56 for 
polyunsaturated fat 21, 26. Caffeine intake was estimated from consumption of coffee and 
other caffeine-containing drinks and foods as reported on the FFQ 27. For smoking status, 
participants were asked whether they had ever smoked more than 100 cigarettes during their 
lifetime. Ever smokers were further asked about typical number of cigarettes smoked per 
day, current smoking status, and, for past smokers, the number of years since they last 
smoked27. Both current smoking and higher caffeine intake was associated with lower risk 
of PD in this cohort as expected22, 27.
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Our primary exposures of interest were dietary intakes of total fat, individual types of fat 
and individual types of fatty acids. We calculated total n-6 PUFA intake as the sum of 
intakes of 18:2 and 20:4 fatty acids and total n-3 PUFA intake as the sum of intakes of 18:3, 
18:4, 20:5, 22:5, and 22:6 fatty acids 28. To account for total energy intake in the analyses, 
we used the multivariate nutrient density method 29. Exposures of interest were first 
expressed as percentage of total energy intake and then categorized into quintiles with the 
lowest quintile as the reference group. Odds ratios (ORs) and 95% confidence intervals 
(CIs) were derived from multivariate logistic regression models, adjusting for age (year, 
continuous variable), gender, race/ethnicity (Non-Hispanic White, Non-Hispanic Black, 
Hispanic, Asian, Pacific Islander, or American Indian/Alaskan Native and Unknown), 
caffeine intake (mg/day, continuous variable), smoking status (never, ever and current), and 
total energy intake (Kcal/day, continuous variable).
Only 56.2% of the original cohort enrollees participated in the cohort’s follow-up survey 
and their baseline population characteristics were significantly different from those excluded 
from the analysis (data not shown). We therefore conducted additional analyses using the 
inverse probability weighting method to examine potential selection biases from death or 
non-participation in the follow-up survey 30. In doing this, we used a directed acyclic 
graph 31 to analyze the following potential confounders identified from previous 
publications: age, gender, race/ethnicity, smoking status, caffeine intake, physical activity, 
body mass index (BMI), education, marital status, total energy intake, vitamin E intake, iron 
intake, alcohol use, non-steroidal anti-inflammatory drug use, diabetes diagnosis, and self-
reported health status. As a result, we identified two minimally sufficient adjustment sets: 
(1) age, gender, physical activity, race/ethnicity, smoking, caffeine intake, diabetes, alcohol, 
BMI, and total energy intake; (2) age, gender, physical activity, race/ethnicity, smoking, 
caffeine intake, diabetes, and self-reported health status (Supplementary Figure 1). We used 
the second minimally sufficient adjustment set as the final model because it had less missing 
data on covariates than the first.
We then used the stabilized inverse probability weights to adjust for covariates in the second 
minimally sufficient adjustment set and to account for non-participation in the follow-up 
survey 30, 32. We calculated separate stabilized weights to adjust for potential confounders 
and potential selection bias, respectively. For stabilized confounding weights, we calculated 
the numerators of these weights as predicted probabilities of exposure from an intercept only 
model and the denominators of these weights as predicted probabilities of exposure from a 
model including the covariates in the second minimally sufficient adjustment set as 
explanatory variables. For stabilized selection weights, we calculated the numerators of 
these weights as predicted probabilities of not dropping out of the cohort conditional on the 
exposure of interest and the denominators of these weights as predicted probabilities 
conditional on the exposure of interest and the covariates in the second minimally sufficient 
adjustment set. We then calculated the overall stabilized weight as the product of the two 
weights. The overall stabilized weight was finally applied to logistic regression models for 
PD risk that contained the exposure of interest as the only explanatory variable 30. We used 
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robust variance estimates to calculate 95% CIs because using weights induced within-
subject correlation 33.
In addition to the primary analyses, we also conducted stratified analyses according to age 
(< 62 and ≥ 62), sex, smoking status (never and ever) and caffeine intake (< 234 and ≥ 234 
mg/day). Statistical interactions were tested by adding a multiplicative interaction term to 
the logistic regression model. All statistical analyses were performed using Stata 12.0 
(College Station, TX, USA) and P < 0.05 was considered as statistically significant.
Standard protocol approvals, registrations and patient consent
Participants consented to the study by returning survey questionnaires. The study protocol 
was approved by the Institutional Review Board of the National Institute of Environmental 
Health Sciences and the Special Studies Institutional Review Board of the National Cancer 
Institute.
Results
Characteristics of study population
Table 1 presents the baseline characteristics of the study population according to quintiles of 
total fat intake. The median intakes of total fat as percentages of energy intake ranged from 
20.1% in the lowest quintile to 39.5% in the highest quintile. Participants with higher fat 
intake were more likely to be men, non-Hispanic Whites and current smokers. They also 
were more likely to report higher intakes of caffeine, total energy, and cholesterol, but lower 
intake of carbohydrate. Further, they on average had a higher BMI and were more likely to 
report diabetes and poorer health status.
Associations between dietary fat intake and PD risk
After adjusting for potential confounders, intakes of total energy and total fat each showed a 
weak positive association with PD risk with borderline significant dose-response 
relationship (Table 2). In the inverse probability weighted analyses, the association with 
total energy intake was slightly stronger whereas the one for total fat intake was modestly 
attenuated. Among individual types of fat, there were weak positive associations between 
PD risk and intakes of total PUFA and n-6 PUFA. For example, compared with the lowest 
quintile, the OR was 1.23 (95% CI=1.02–1.49, P for trend=0.02) for the highest quintile of 
n-6 PUFA intake. The association was also borderline statistically significant in the inverse 
probability weighted analyses (P for trend=0.03). When we examined the n-3 to n-6 ratio in 
relation to PD risk, we found that participants in the fourth quintile had a lower risk for PD 
as compared with those in the first quintile (OR=0.81, 95% CI=0.38–0.98), but the P for 
trend was not statistically significant (P for trend=0.12). None of these associations 
remained statistically significant after Bonferroni correction for multiple comparisons. 
Intake of other types of fat or macronutrients was not associated with PD risk.
We further examined specific types of PUFA in relation to PD risk (Table 3). As expected, 
intake of linoleic acid showed a weak positive association with the risk for PD. No other n-6 
fatty acids or n-3 fatty acids were associated with the risk for PD.
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Overall, we did not observe significant interactions between intakes of these fatty acids and 
age, sex, smoking or caffeine intake (Supplementary Table 1). The positive associations 
observed in the main analyses were however apparently limited to never smokers and heavy 
coffee drinkers.
Discussion
In this large prospective study among older US adults, we found that overall fat intake was 
not associated with the risk for PD. There were weak positive associations of PD risk with 
higher intakes of the n-6 PUFA and linoleic acid; however these associations did not persist 
adjustments for multiple comparisons. To the best of our knowledge, this study is to date the 
largest prospective analysis on dietary fat and PD risk. Further, we excluded PD cases 
diagnosed prior to 2000 from the analysis with the hope to reduce concern about reverse 
causation due to changing dietary habits of PD patients in the years leading to a PD 
diagnosis.
Dietary fat intake may affect PD risk because fats, particularly PUFA, may contribute to 
oxidative stress and neuroinflammation. Neural membranes are rich in PUFA and are 
therefore sources of oxygen radicals through lipid peroxidation 34. Oxidation of membrane 
PUFA may cause mitochondrial dysfunction and damage cellular components, thus 
contribute to neuronal degeneration 35. In addition, PUFA are essential components of glial 
cell membranes and regulate the production of prostaglandins and proinflammatory 
cytokines 6. Exacerbated or prolonged inflammatory processes in the brain may play a key 
role in neurodegeneration 36. Furthermore, PUFA may promote α-synuclein oligomerization 
and aggregation in cultured dopaminergic cells and increase its deposit into intraneuronal 
Lewy-like inclusions 37. The majority of membrane PUFA is synthesized from dietary n-6 
linoleic and n-3 α-linoleic acids, which are also precursors for the synthesis of long chain 
PUFA by desaturation and elongation reactions 38. The n-3 PUFA are anti-inflammatory, 
while n-6 PUFA are precursors of proinflammatory prostaglandins. Therefore our finding 
that n-6 PUFA intake was associated with higher PD risk is biologically plausible.
To the best of our knowledge, the associations between dietary fat intake and PD have been 
investigated in approximately a dozen epidemiological studies, including both case-control 
studies and prospective studies. Several earlier case-control studies reported a positive 
association with intake of total fat 9, 11 or animal/saturated fat 9, 10, but these findings were 
largely not confirmed in later studies 12, 13, 18, 19. For specific types of dietary fats, the 
findings are largely null 12, 18, although some interactions were reported between specific 
types of dietary fats (saturated or PUFA) and iron intake 18 or pesticide exposure 19. Most of 
these case-control studies used prevalent PD cases that had the diseases for years at the time 
of the study 9–13, 18, 19 and a couple of studies did not specifically query dietary intake prior 
to disease diagnosis 12, therefore these findings might have been affected by recall bias and 
reverse causation that dietary intakes might have changed as a result of the disease.
Prospective cohort studies assessed diet prior to disease diagnosis and thus are relatively less 
prone to reverse causality and recall bias. However, diet in prospective studies is often 
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evaluated at one point in mid- or late- adulthood, which may not capture the time windows 
that are relevant to disease etiology. Further, prospective studies may not be immune from 
reverse causation because patients may suffer from premotor symptoms which may affect 
dietary intakes. Some cohort studies, but not all, suggested lower risk of PD with higher 
intakes of one or more types of fatty acids, although the results were not always statistically 
significant nor consistent for specific types of fatty acids 14–17, 20. Only one previous study 
evaluated the dietary intake repeatedly and conducted lag analyses that excluded the first 
several years of follow-up 16. The Health Professionals Follow-up Study and the Nurses’ 
Health Study included 359 incident PD cases, nearly the total number of cases of the other 
four cohorts combined 16. This study did not identify associations between PD risk and total 
fat or individual types of fatty acids with the exception of a borderline inverse association 
with arachidonic acid 16.
Compared to previous prospective studies, our current study was substantially larger with 
1,087 PD cases and 299,617 controls. This large sample size provided better power to detect 
associations and facilitated adjustment for multiple covariates and gender-specific analyses. 
Our analyses only included PD cases diagnosed after 2000, at least four to five years after 
exposure assessment, which might have further alleviated concern about reverse causality. 
This large population also encompassed a large range of fat intakes. Fat intakes in this 
cohort have been associated with the risk of various types of chronic diseases, such as 
prostate cancer, chronic liver disease and hepatocellular carcinoma and pancreatic cancer in 
a manner consistent with their metabolic effects 28, 39, 40.
Our study also had several limitations. First, PD cases were self-reported and thus reporting 
and diagnostic errors were inevitable. We confirmed 88% of diagnoses in patients for whom 
we obtained medical information from their treating neurologists and we further removed 
patients with identified reporting errors and misdiagnoses from the analyses. However, we 
were unable to include PD cases who did not report their diagnosis on the follow-up 
questionnaire as cases in the analysis, and this might have biased the analyses if fat intakes 
of these cases were systematically different from cases who did report their diagnoses. 
Further, as the exact date of diagnosis was only available for some cases, we were unable to 
perform time to event survival analyses. Secondly, fat intakes were assessed as part of a 
dietary history questionnaire at study baseline; we could not exclude the possibility of 
measurement errors and residual confounding. Thirdly, PD may have a long prodromal 
period and we only had dietary assessment once at baseline. Although we only included PD 
cases diagnosed after 2000, we could not exclude the possibility of reverse causality if some 
PD patients’ dietary habits had been affected early in the prodromal period. Fourthly, the 
analysis was performed among participants of the follow-up survey, and therefore the 
possibility of selection bias cannot be excluded. Nevertheless, we used the inverse 
probability weighting analysis to account for this potential selection bias and found similar 
results. Finally, the cohort was predominantly non-Hispanic white, so results may not be 
readily generalizable to other populations.
In summary, we conducted the largest prospective study to date examining the associations 
between dietary fat intake and PD risk. Dietary intakes of fat in general were not found to be 
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associated with the risk for PD. The weak positive association between intake of n-6 PUFA 
and PD needs confirmation and further investigation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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